CVE:GAP - PharmaGap Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PharmaGap Inc. (PharmaGap) is a development-stage company. The Company is principally engaged in drug development and out-licensing of drug compounds. The Company is focused on the development of novel drugs for treatment of cancer and other human disease conditions. PharmaGap's lead drug compound, GAP-107B8, is in the pre-clinical testing stage and has shown in vitro and in vivo efficacy in selected cancer types. During the year ended December 31, 2011, the Company commenced specific programs to further elucidate information regarding the pharmacokinetics and toxicity profiles of GAP-107B8. A program to develop liposomal delivery formulations of GAP-107B8 in order to optimize the delivery and safety of the drug compound was completed during 2011. The Company is developing GAP-107B8 for first clinical trials in ovarian cancer, using the intra-peritoneal route of administration.

Receive GAP News and Ratings via Email

Sign-up to receive the latest news and ratings for GAP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
WebN/A
Phone+1-613-2873118

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

PharmaGap (CVE:GAP) Frequently Asked Questions

What is PharmaGap's stock symbol?

PharmaGap trades on the Canadian Venture Exchange (CVE) under the ticker symbol "GAP."

Has PharmaGap been receiving favorable news coverage?

News articles about GAP stock have trended somewhat positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. PharmaGap earned a daily sentiment score of 0.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an effect on the stock's share price in the near term.

What other stocks do shareholders of PharmaGap own?

How do I buy shares of PharmaGap?

Shares of GAP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How can I contact PharmaGap?

PharmaGap's mailing address is 1000 Innovation Drive, Suite 400, OTTAWA, ON K2K 2K7, Canada. The company can be reached via phone at +1-613-2873118.


MarketBeat Community Rating for PharmaGap (CVE GAP)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  26 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  63
MarketBeat's community ratings are surveys of what our community members think about PharmaGap and other stocks. Vote "Outperform" if you believe GAP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GAP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/22/2019 by MarketBeat.com Staff

Featured Article: What is a stock buyback?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel